The CESAR Central European Society for Anticancer Drug Research - EWIV is granting every other year the CESAR Award amounting to EURO 6.000,-- to scientists in Preclinic and Clinic for outstanding contributions in the field of translational research in the development of antitumoral agents.
CESAR Award 2007:
Dr. Claudia Friesen
„Overcoming Chemo- and Radioresistance with Bismuth-213 labelled CD45-Antibodies in Leucemia Cells“
Prof. Dr. Thomas Szekeres
"Use of Resveratrol Analoga as Antimetabolites in the Therapy of Tumours"
CESAR Award 2005:
Univ.-Doz. Dr. Eberhard Gunsilius
„Evidence from a leukemia model for the maintenance of the blood vascular endothelium by bone-marrow derived endothelial cells“
Univ.-Prof. Dr. Doris Marko
„Cyclic 3‘, 5‘ – Nucleotide Phosphodiesterases: Potential Targets for Anticancer Therapies“
CESAR Award 2003:
Professor Dr. Gert Fricker:
“Transport of Paclitaxel (Taxol) across the blood brain barrier in vitro and in vivo”
Dr. Joachim Drevs
„PTK787/ZK 222584, a Specific Vascular Endothelial Growth Factor-Receptor Tyrosine Kinase Inhibitor, Affects the Anatomy of the Tumor Vascular Bed and the Functional Vascular Properties as Detected by Dynamic Enhanced Magnetic Resonance Imaging” | 
printversion
recommend this page